Law Enforcement In The Health Care Industry: What Do New Cases Against Novartis Tell Us?
May 9, 2013 | The Insider: White Collar Defense and Securities Enforcement
In recent years, pharmaceutical companies have faced criminal investigations and charges in regard to alleged off-label marketing of prescription drugs and kickbacks to doctors. For this reason, the filing last month of two civil cases against Novartis was noteworthy and may aid defense lawyers in their efforts to oppose criminal charges being filed against clients in the health care industry. [...]